Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
Pfizer last week selected winners in reviews for the creative accounts of three drugs formerly handled by IPG’s Deutsch. IPG’s McCann-Erickson beat out Havas’ Arnold, WPP’s Berlin Cameron/Red Cell, Publicis and Omnicom’s TBWA\Chiat\ Day for Bextra. For Zoloft, Publicis’ Kaplan Thaler Group overcame Arnold, Publicis and Omnicom’s Merkley Newman Harty & Partners. Berlin Cameron bested Kaplan Thaler, Merkley and TBWA\C\D for Zyrtec. Billings for each account are estimated at $50 million-plus. Separately, Pfizer named Arnold and Kaplan Thaler finalists for duties on the $80 million Celebrex account; WPP’s J.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in